Article
The effect of TGF-β1 polymorphisms on pulmonary disease progression in patients with cystic fibrosis.
BMC pulmonary medicine - 7 May 2022
Trojan T, Alejandre Alcazar Miguel A, Fink G, Thomassen J C, Maessenhausen M V, Rietschel E, Schneider P M, van Koningsbruggen-Rietschel S
Abstract excerpt
BACKGROUND: Transforming Growth Factor-β1 (TGF-β1) is a genetic modifier in patients with cystic fibrosis (CF). Several single nucleotide polymorphisms (SNPs) of TGF-β1 are associated with neutrophilic inflammation, lung fibrosis and loss of pulmonary function. AIM: The aim of this study was to assess the relationship between genetic TGF-β1 polymorphisms and pulmonary disease progression in CF patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
